MARKET

RGEN

RGEN

Repligen
NASDAQ
129.82
+1.26
+0.98%
Closed 16:27 07/09 EDT
OPEN
128.47
PREV CLOSE
128.56
HIGH
130.82
LOW
127.84
VOLUME
577.81K
TURNOVER
0
52 WEEK HIGH
182.52
52 WEEK LOW
102.97
MARKET CAP
7.29B
P/E (TTM)
-285.9471
1D
5D
1M
3M
1Y
5Y
1D
Evercore ISI Sticks to Its Hold Rating for Repligen (RGEN)
TipRanks · 1d ago
Repligen And 2 Other Stocks That May Be Trading Below Estimated Value
Simply Wall St · 2d ago
Weekly Report: what happened at RGEN last week (0630-0704)?
Weekly Report · 2d ago
RBC Capital Sticks to Its Buy Rating for Repligen (RGEN)
TipRanks · 07/01 18:46
Weekly Report: what happened at RGEN last week (0623-0627)?
Weekly Report · 06/30 09:09
Repligen Insiders Sell US$6.9m Of Stock, Possibly Signalling Caution
Simply Wall St · 06/26 13:36
REPLIGEN <RGEN.O>:  BARCLAYS INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $150
Reuters · 06/25 09:02
U.S. RESEARCH ROUNDUP- Fedex, Omnicom Group, Texas Instruments
Reuters · 06/25 07:17
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.